1. P138 Urinary leukotriene E4 (uLTE4) pharmacodynamic biomarker for early decision making in the AZD9898 adaptive phase i study. (December 2018) Authors: Betts, J; Larsson, B; Jauhiainen, A; Hegelund-Myrbäck, T; Leander, J; Berton, A; Glader, P; Aurell Holmberg, A; Santisteban, Z; Franzén, J; Albayaty, M; Keen, C; Kristensson, C Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome. (1st October 2014) Authors: Ostadkarampour, M; Eklund, A; Moller, D; Glader, P; Olgart Höglund, C; Lindén, A; Grunewald, J; Wahlström, J Journal: Clinical and experimental immunology Issue: Volume 178:Number 2(2014:Nov.) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗